Intended for healthcare professionals

Practice Short cuts

Etoricoxib and diclofenac are associated with similar cardiovascular risks

BMJ 2006; 333 doi: (Published 23 November 2006) Cite this as: BMJ 2006;333:1113

This article has a correction. Please see:

It's now clear that non-steroidal anti-inflammatory drugs (NSAIDs) that selectively inhibit cyclo-oxygenase-2 (COX 2) are linked to thrombotic cardiovascular events such as heart attack. But experts are still debating whether this risk extends to more traditional NSAIDs. In a pooled analysis …

View Full Text

Log in

Log in through your institution


* For online subscription